Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions. - Wikidata - awgldk - TriplyDB

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.

http://www.wikidata.org/entity/Q47404143

about

The role of c-kit and imatinib mesylate in uveal melanoma.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2 Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.Interstitial cells of Cajal in health and disease. Part II: ICC and gastrointestinal stromal tumours.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.

P2860

Q21245647-97340562-C689-49D1-BBA6-9647BDE80C39 Q30438929-D76AE8B0-E4D1-4CAE-B8C1-AFC32AF5281F Q33994399-9E55F053-A47A-45DA-8E18-A504945E3E52 Q35234354-B5CBD793-88FC-4DF1-88BF-782DD98FF7EB Q35771115-D708B4C7-95AD-4E75-8E17-847FED245F2A Q36455153-937DE3DA-C206-4E01-8DF2-060D7D2210CE Q36707574-09141203-AA53-4965-A116-82095071C367 Q37288883-785389A5-B320-4D8D-8D91-2CCA08B85F49 Q38431670-50C0B0B1-76D0-48DD-9045-27C50906777E Q54372069-1EE84827-F226-40F6-8422-BB623F79DC49

P2860

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.

http://www.wikidata.org/entity/Q47404143

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Immunohistochemical expression ...... cutaneous melanocytic lesions.

@en

Immunohistochemical expression of vascular endothelial growth factor

@nl

type

label

Immunohistochemical expression ...... cutaneous melanocytic lesions.

@en

Immunohistochemical expression of vascular endothelial growth factor

@nl

prefLabel

Immunohistochemical expression ...... cutaneous melanocytic lesions.

@en

Immunohistochemical expression of vascular endothelial growth factor

@nl

P1433

Q47404143-4FF690FD-C6AB-4321-A29A-5A92F252E44C

P1476

Q47404143-60FCF3A1-EBBD-4B76-BB3A-6132C3DDB0FA

P2093

Q47404143-231B3D10-5ABD-435D-8D7F-2C57B4B6FD48

Q47404143-3214D5ED-D489-40CF-852C-B387E1F833BB

Q47404143-69CC15AF-3C75-4166-A1B4-D4FE75CA12D4

Q47404143-8F0590F8-7D9E-4DA4-BD9F-DA1F1010033D

Q47404143-A4B6606B-A569-4A49-BC51-CBCADBD9AED1

Q47404143-B6962E1C-2371-4F70-AFBC-42CA305E2DDC

P2860

Q47404143-048171DC-D8DA-4C37-A7EB-537EAB9EA47C

Q47404143-0903CFCD-8058-4BA5-A475-0CCBC1A43EAD

Q47404143-1B3524C7-A170-427D-8FF8-C30DA7A67B1C

Q47404143-1E22AFE8-D89F-488B-A28E-311C2800CB4D

Q47404143-248C306F-FC75-478A-84CE-AA88A3878549

Q47404143-431CB32E-41EA-4912-8E29-9B5C9B2696B2

Q47404143-54444D16-912A-4499-8702-6FD4FCF6A7DE

Q47404143-5EBECF1D-DD6E-4C3A-8960-0F5E32D66841

Q47404143-6810CDEC-4D99-4CA4-9C6C-E6E79F306C2B

Q47404143-74208681-B2E3-410D-8DD1-418B80BB027C

P304

Q47404143-93C05B48-299E-48D5-AFE4-FD4244036DB1

P31

Q47404143-D505AC26-B1E0-48E9-A44D-D652C2E6E395

P356

Q47404143-C51B38B2-1BC8-4B68-A6C7-45B6A2E5FA7B

P433

Q47404143-42AC9E0D-0196-4D5C-838F-5D668E82CAC8

P478

Q47404143-3E61A867-3C2F-463A-9769-1C97B67739CC

P577

Q47404143-1B5B439B-F9F9-45E1-8827-0F6B9FFECC44

P698

Q47404143-BD0B54D4-7F38-4DB6-A81C-8E93F588E5B0

P921

Q47404143-22C9E029-F834-41DB-B37E-954E294B9813

P356

106689690401200206

P1433

International Journal of Surgical Pathology

P1476

Immunohistochemical expression ...... cutaneous melanocytic lesions.

@en

P2093

Aikaterini Zioga

http://www.w3.org/2001/XMLSchema#string

Anna Batistatou

http://www.w3.org/2001/XMLSchema#string

Dimitrios Stefanou

http://www.w3.org/2001/XMLSchema#string

Dionysios J Papachristou

http://www.w3.org/2001/XMLSchema#string

Evdokia Arkoumani

http://www.w3.org/2001/XMLSchema#string

Niki J Agnantis

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis

The biology of vascular endothelial growth factor

What is the evidence that tumors are angiogenesis dependent?

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Protein tyrosine kinases in malignant melanoma.

Gene regulation in melanoma progression by the AP-2 transcription factor.

Dermatological aspects of angiogenesis.

Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications.

Apoptosis and melanoma: molecular mechanisms.

P304

133-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/106689690401200206

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15173918

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry